CRON - Cronos Group Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
-0.10 (-1.17%)
At close: 4:00PM EST

8.45 0.00 (0.00%)
After hours: 7:58PM EST

Stock chart is not supported by your current browser
Previous Close8.55
Bid8.43 x 800
Ask8.45 x 900
Day's Range7.99 - 8.84
52 Week Range5.12 - 15.30
Avg. Volume21,829,475
Market Cap1.519B
Beta (3Y Monthly)3.49
PE Ratio (TTM)845.00
EPS (TTM)0.01
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Aurora Cannabis sales spike 260% after legalization in Canada
    Yahoo Finance13 hours ago

    Aurora Cannabis sales spike 260% after legalization in Canada

    Aurora Cannabis reported fiscal Q1 earnings and saw a 260% spike in sales year over year.

  • Do Options Traders Know Something About Cronos (CRON) Stock We Don't?
    Zacks13 hours ago

    Do Options Traders Know Something About Cronos (CRON) Stock We Don't?

    Investors need to pay close attention to Cronos (CRON) stock based on the movements in the options market lately.

  • ACCESSWIRE4 days ago

    Cannabis Utility Company Could Skyrocket

    HENDERSON, NV / ACCESSWIRE / November 8, 2018 / Pot stocks have been on quite a roll recently, after Tuesday's election results yielded some great news for the sector, including Michigan legalizing recreational ...

  • GlobeNewswire5 days ago

    Cannabis Industry Gets Boost and Stocks Rise after 2018 Midterm Results and Jeff Sessions Resignation: DirectView Holdings (OTC: DIRV), Cronos Group, Tilray, Canopy Growth

    Voters in Missouri approved Amendment 2 on Tuesday, making it the 31st state in the nation to adopt an effective medical marijuana law. Effective medical marijuana laws have now been adopted in 31 states, including Missouri, as well as in D.C. and the U.S. territories of Guam, Puerto Rico and the Northern Mariana Islands. Eighteen other states have adopted medical marijuana laws that are ineffective because they are either unworkable or exceptionally restrictive.

  • ACCESSWIRE5 days ago

    Healthcare & Marijuana Stocks See Common Ground After Elections

    / Healthcare stocks have been trending higher ahead of US midterm elections and now that the results are in, sector shares are rallying. Recent news across several marijuana stocks has shown this connection between healthcare and marijuana with several companies planning to expand into this industry and take advantage of its appeal in the medical community Today we're taking a closer look at 3 stocks in the space including Premier Health Group, Inc. (OTC:PHGRF) (CSE:PHGI), Aphria (APHA) (APHQF) (APH) and Cronos Group (CRON) (CRON.TO). Premier Health Group, Inc. (OTC:PHGRF) (CSE:PHGI) announced this week that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019.

  • ACCESSWIRE5 days ago

    These Cannabis Stocks Are on Fire

    HENDERSON, NV / ACCESSWIRE / November 7, 2018 / After a bit of a lull in the cannabis market, some of the top companies are on a roll again. We've highlighted the ones you should be paying attention to. ...

  • ACCESSWIRE6 days ago

    Today’s Research Reports on Stocks to Watch: Canopy Growth and Cronos

    NEW YORK, NY / ACCESSWIRE / November 7, 2018 / Pot stocks continued on their tear on Tuesday with both Canopy Growth and Cronos Group seeing gains ahead of the United States midterm elections. Canopy closed ...

  • ACCESSWIRE6 days ago

    A Major Migration Afoot: Canadian Cannabis Stocks Cross the Border

    This is no Fox News hype about a caravan we're talking about here--it's the increasing number of Canadian cannabis stocks listing on American exchanges. Tilray(TLRY) has shot up from just around $22 per share at the beginning of 2018 to $300 very briefly. Sure, Tilray's market cap slid in late October and its founders dipped down below the billionaire threshold, but they probably aren't feeling too sorry for themselves.

  • ACCESSWIRE6 days ago

    3 Marijuana Stocks That Have Moved Up Big In The Last Week

    CORAL GABLES, FL / ACCESSWIRE / November 6, 2018 / Marijuana stocks have seen a surge of attention this year. Canaccord analyst Bobby Burleson said in a research note, "We believe his year's midterms ...

  • Analysts Estimate Cronos Group (CRON) to Report a Decline in Earnings: What to Look Out for
    Zacks6 days ago

    Analysts Estimate Cronos Group (CRON) to Report a Decline in Earnings: What to Look Out for

    Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • ACCESSWIRE6 days ago

    CBD Stocks on The Rebound

    HENDERSON, NV / ACCESSWIRE / November 6, 2018 / As the stock market plummeted early October cannabis companies stayed strong, buoyed up by legislative changes in Canada. The cannabis market appears set ...

  • ACCESSWIRE7 days ago

    3 Marijuana Stocks Investors Are Watching Ahead Of Midterms

    CORAL GABLES, FL / ACCESSWIRE / November 5, 2018 / The upcoming US midterm elections could be pivotal in progressing marijuana legalization. Additionally, if Jeff Sessions - who calls pot a "very real danger" and said "Good people don't smoke marijuana" - leaves, a more clear road to legalization is also a possibility. President Trump has publicly expressed his frustration over Sessions' decision to recuse himself from the investigation into whether the Trump campaign colluded with Russia in the 2016 presidential election.

  • GlobeNewswire7 days ago

    DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Specifically, Cronos’ distribution agreements with provinces of Canada were insignificant.